Synthesis and Preclinical Evaluation of the Fibrin-Binding Cyclic Peptide <sup>18</sup>F-iCREKA: Comparison with Its Contrasted Linear Peptide

<div>(a) %ID/g of tumors and organs of <sup>18</sup>F-NOTA-LP and <sup>18</sup>F-NOTA-iCREKA in U87MG xenograft-bearing mice and Caov3 xenograft-bearing mice on micro-PET; (b) %ID/g of tumors and organs in U87MG xenograft-bearing mice for <sup>18</sup>F-NOTA-LP and <sup>18</sup>F-NOTA-iCREKA in the biodistribution experiment.</div>

Contrast Media & Molecular Imaging

fig6

Figure 6

Figure 6: Synthesis and Preclinical Evaluation of the Fibrin-Binding Cyclic Peptide <sup>18</sup>F-iCREKA: Comparison with Its Contrasted Linear Peptide 

Contrast Media & Molecular Imaging

Synthesis and Preclinical Evaluation of the Fibrin-Binding Cyclic Peptide 18F-iCREKA: Comparison with Its Contrasted Linear Peptide

Figure 6

Synthesis and Preclinical Evaluation of the Fibrin-Binding Cyclic Peptide ¹⁸F-iCREKA: Comparison with Its Contrasted Linear Peptide